Trump administration nearing deal to lower prices of obesity drugs


The Trump administration is expected to announce this week a deal with drugmakers Eli Lilly and Novo Nordisk to lower the prices of their obesity drugs sold through TrumpRX.


The Trump administration is expected to announce this week a deal with drugmakers Eli Lilly and Novo Nordisk to lower the prices of their obesity drugs sold through TrumpRX.